2026年是“十五五”开局之年,站在新起点,恒瑞医药将紧扣"十五五"规划纲要要求,加速推进医药创新。相关人士表示,一、聚焦临床刚需与重大疾病,提升从0到1的原始创新能力,产出更多具有全球影响力的创新成果。二、加快创新药国际化进程,在满足国内临床需求的同时,让"中国创新药"更快更好服务全球患者。作为国内大型药企,恒瑞医药以创新转型为核心引擎,已构建起以自主原研为驱动的产品与技术体系,公司已有20多款...
Source Link2026年是“十五五”开局之年,站在新起点,恒瑞医药将紧扣"十五五"规划纲要要求,加速推进医药创新。相关人士表示,一、聚焦临床刚需与重大疾病,提升从0到1的原始创新能力,产出更多具有全球影响力的创新成果。二、加快创新药国际化进程,在满足国内临床需求的同时,让"中国创新药"更快更好服务全球患者。作为国内大型药企,恒瑞医药以创新转型为核心引擎,已构建起以自主原研为驱动的产品与技术体系,公司已有20多款...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.